Diagnosis and treatment of deep vein thrombosis

Western Journal of Medicine

Volumn 173, Issue 3, 2000, Pages 194-197

  Ofri, D ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ALGORITHM; ANTICOAGULATION; ARTICLE; BLEEDING; CASE REPORT; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DOPPLER FLOWMETER; FEMALE; HUMAN; PHLEBOGRAPHY; PHYSICAL EXAMINATION;

ALGORITHMS; AMBULATORY CARE; ANTICOAGULANTS; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS; THROMBOPHILIA; TIME FACTORS; VENOUS THROMBOSIS;

EID: 0033815737     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: 10.1136/ewjm.173.3.194     Document Type: Article

References (21)

1. Value of assessment of pretest probability of deep-vein thrombosis in clinical management
2. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism
3. Limitations of impedance plethysmography in the diagnosis of clinically suspected deep-vein thrombosis
4. Noninvasive diagnosis of deep venous thrombosis: McMaster Diagnostic Imaging Practice Guidelines Initiative
5. Ruling out acute deep vein thrombosis by ELISA plasma D-dimer assay versus ultrasound in inpatients more than 70 years old
6. Plasma D-dimer levels in patients with deep vein thrombosis
7. Does this patient have deep vein thrombosis?
8. D-Dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis: Prospective cohort study: The Multicentre Italian D-Dimer Ultrasound Study Investigators Group
9. Is embolic risk conditioned by location of deep venous thrombosis?
10. Fifth ACCP Consensus Conference on Antithrombotic Therapy
11. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
12. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home: The Tasman Study Group
13. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
14. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: A cost-effective analysis
15. Cost-effectiveness of low-molecular-weight heparin and unfractionared heparin in treatment of deep vein thrombosis
16. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism: Duration of Anticoagulation Trial Study Group
17. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
18. The tisk of recutrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
19. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism
20. Lack of association between venous thrombosis and subsequent malignancy in a retrospective cohort study in young patients